Regimen-stratified Bayesian model-based meta-analysis of targeted biologics in generalised myasthenia gravis: efficacy comparison, mechanism-level class contrast, and endpoint sensitivity with model-informed trial design

Sayantan Shankar Roy, Biswa Mohan Padhy, Abhishek Anil, Debasish Hota, Anand Srinivasan, Apoorva Wasnik

Open source

DOI
10.1007/s00210-026-05939-w
Published
2026-09-22
Container
Naunyn-Schmiedeberg's Archives of Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05939-w,
  title = {Regimen-stratified Bayesian model-based meta-analysis of targeted biologics in generalised myasthenia gravis: efficacy comparison, mechanism-level class contrast, and endpoint sensitivity with model-informed trial design},
  author = {Sayantan Shankar Roy and Biswa Mohan Padhy and Abhishek Anil and Debasish Hota and Anand Srinivasan and Apoorva Wasnik},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  doi = {10.1007/s00210-026-05939-w},
  url = {https://doi.org/10.1007/s00210-026-05939-w}
}

RIS

TY  - JOUR
TI  - Regimen-stratified Bayesian model-based meta-analysis of targeted biologics in generalised myasthenia gravis: efficacy comparison, mechanism-level class contrast, and endpoint sensitivity with model-informed trial design
AU  - Sayantan Shankar Roy
AU  - Biswa Mohan Padhy
AU  - Abhishek Anil
AU  - Debasish Hota
AU  - Anand Srinivasan
AU  - Apoorva Wasnik
PY  - 2026
JO  - Naunyn-Schmiedeberg's Archives of Pharmacology
DO  - 10.1007/s00210-026-05939-w
UR  - https://doi.org/10.1007/s00210-026-05939-w
ER  - 

APA

Roy, S. S., Padhy, B. M., Anil, A., Hota, D., Srinivasan, A., & Wasnik, A. (2026). Regimen-stratified Bayesian model-based meta-analysis of targeted biologics in generalised myasthenia gravis: efficacy comparison, mechanism-level class contrast, and endpoint sensitivity with model-informed trial design. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05939-w

Source records